Coronary artery bypass graft (CABG) surgery has been performed for about 40 years. In 1967, the technique of saphenous vein (SV) bypass grafting was introduced, followed 1 year later by the use of internal thoracic artery (ITA).
Among substances that can initiate severe vasoconstriction, 5-hydroxytryptamine (5-HT) has been identified as playing an important role in the pathogenesis of vascular spasm. [8] [9] [10] [11] [12] [13] Although 5-HT 2A and/or 5-HT 1B/1D receptor subtypes almost exclusively mediate 5-HT-induced vasoconstriction, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] the relative contributions of these receptor subtypes to vasoconstrictions are species-dependent and vascular beddependent. Therefore, the selection of the best pharmacological agent to prevent 5-HT-induced spasm of the bypass grafts used in CABG surgery requires better understanding of the contributions of 5-HT receptor subtypes to vasoconstriction in the clinically used human vessels.
From the viewpoint mentioned above, we revealed that 5-HT-induced vasoconstriction is mediated equivalently via 5-HT 2A and 5-HT 1B receptors in the human ITA. 18) In the human SV, Borton et al. 14) have reported that both 5-HT 1 and 5-HT 2 receptors are involved in vasoconstriction by using a 5-HT 2 receptor antagonist and a 5-HT 1 receptor agonist. However, the relative contributions of 5-HT receptor subtypes that mediate vasoconstriction caused by 5-HT in the human SV are still unclear.
It has been established that, before implantation into the coronary arterial circulation, the segment of SV used as a vein graft is distended by applying high intraluminal pressures with injection of saline or a patient's heparinized blood to check for leaks and to increase the vascular diameter. This fact should be considered in experiments for evaluation of 5-HT receptor subtypes responsible for vascular functions because the distension may influence both contractile and dilatory responses of the SV. 19) The aim of the present study was to elucidate the relative contribution of 5-HT receptor subtypes mediating 5-HTinduced vasoconstriction of the distended human SV obtained from CABG surgery. We examined the effects of sarpogrelate and SB224289, antagonists of 5-HT 2A and 5-HT 1B receptors, respectively, on the 5-HT-induced vasoconstriction and also performed immunolabeling of the 5-HT 2A and 5-HT 1B receptors in the distended SV.
MATERIALS AND METHODS

Preparation of Blood Vessels and Contractile Studies
Segments of the human SV were harvested from patients (nϭ12) who were undergoing CABG surgery at Miyazaki Prefectural Nobeoka Hospital (Miyazaki, Japan). Once the vein was completely freed from connective tissues, it was placed in heparinized saline (0.9% NaCl). The vein was then distended with pressures of 200-400 mmHg achieved by injection of heparinized saline for 15 s. Portions of the dis-tended SV were sectioned according to the desired lengths for bypassing the occluded coronary arteries. We used the remainder of the distended SV for the present experiments. After the residual vein was obtained, it was immediately placed in modified Krebs buffer that had been previously aerated with 95% O 2 -5% CO 2 , and transported to our laboratory within 30 min. The composition of the modified Krebs buffer solution was as follows (in mM): NaCl 118.0, KCl 4.7, NaHCO 3 25.0, MgSO 4 1.2, KH 2 PO 4 1.1, CaCl 2 2.5, ethylenediaminetetraacetic acid (EDTA) 0.01 and glucose 11.0. The final pH of the modified Krebs buffer was adjusted to 7.4. The vessel was carefully cut into 2-mm rings. Each ring was suspended between stainless steel hooks in a 5-ml tissue bath containing modified Krebs buffer maintained at 37°C and continuously aerated with 95% O 2 -5% CO 2 . One hook was connected to a force transducer (Nihon-Kohden, Tokyo, Japan) to record the isometric tension on a computer system (PowerLab8/30; Bio Research Center Co., Ltd., Nagoya, Japan). Rings were stretched progressively to the optimal resting tension (2.0 g) and were allowed to equilibrate for 1 h. The buffer was changed every 30 min. Thereafter, the presence of functional endothelium was assessed. Rings were preconstricted with noradrenaline (1 mM), and acetylcholine (30 nM) was added to the organ bath. If a relaxant effect of acetylcholine was observed, we considered functional endothelium to be present. The preparation was washed three times with fresh Krebs buffer solution. After the tension of the ring had returned completely to the basal level, vehicle (Krebs buffer solution), sarpogrelate (0.03, 0.1, 0.3 or 1.0 mM) or SB224289 (0.03, 0.1, 0.3 or 1.0 mM) was added to the bath, and 30 min later, the ring was challenged with 5-HT (1.0 mM). In another series of experiments, cumulative concentration-response curves to 5-HT over the concentration range 1.0 nM-10.0 mM were constructed after treatment with vehicle, sarpogrelate (1.0 mM), SB224289 (1.0 mM), or sarpogrelate (1.0 mM) plus SB224289 (1.0 mM). All isometric force measurements are given as relative values to the contraction induced by 60 mM KCl added at the end of the experiment.
Immunohistochemical Staining and Analysis of 5-HT 2A and 5-HT 1B Receptors The distended SV were fixed in 10% formaldehyde for 24 h at 4°C and then embedded in paraffin. Paraffin-embedded sections (3 mm thick) were stained with hematoxylin and eosin (HE), and with antibodies against a-smooth muscle actin (SMA, 1A4, DAKO, Glostrup, Denmark), goat polyclonal anti-5-HT 1B receptor (Santa Cruz Biotechnology Inc., California, U.S.A.) and mouse monoclonal anti-5-HT 2A receptor (BD Biosciences Japan, Tokyo, Japan).
18) The sections were stained with Envision, anti-mouse immunoglobulin G (IgG) secondary antibody and horseradish peroxidase connected with a polymer, (DAKO) or donkey anti-goat IgG secondary antibody (Jackson Immuno Research, Inc., West Grove, PA, U.S.A.). Horseradish peroxidase activity was visualized using 3,3Ј-diaminobenzidine tetrahydrochloride, and the sections were faintly counterstained with Meyer's hematoxylin. Immunostaining controls included non-immune mouse IgG or nonimmune goat serum instead of the primary antibodies.
Areas of positive immunostaining for 5-HT 1B and 5-HT 2A receptors were analyzed using a color imaging morphometry system (Win Roof, Mitani, Fukui, Japan). Briefly, the commands for the extraction of specified colors were used to extract the immunopositive areas. Extraction of each color was carried out using specific protocols based on the hue, lightness, saturation (HLS) color parameters. Data are expressed as percentage of immunopositive areas in the venous wall. 20) Two investigators (A.Y. and Y.A.) who were blinded to the treatment assignments performed the morphological analyses.
Drugs The following drugs were used: 5-hydroxytryptamine (5-HT), SB224289 (2,3,6,7-tetrahydro-1Ј-methyl-5-[2Ј-methyl-4Ј(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl]furo [2,3f] indole-3-spiro-4Ј-piperidine hydrochloride), 5-HT 1B receptor selective antagonist, (Sigma Chemical Co., St. Louis, MO, U.S.A.), sarpogrelate, a selective 5-HT 2A receptor antagonist (Mitsubishi Pharma Co., Osaka, Japan), acetylcholine chloride (Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan) and noradrenaline (Sankyo Co., Ltd., Tokyo, Japan).
Ethics The Ethics Committee of Miyazaki Prefectural Nobeoka Hospital and The Ethics Committee of Kyushu University of Health and Welfare approved the project. All patients submitted written consent to participate in the study.
Statistical Analysis In contractile studies, data express the meanϮS.E.M. For statistical analysis, we used one-way or two-way analysis of variance (ANOVA) (Statistical Package for Social Science 16.0J for Windows) with multiple comparison using Tukey test. For immunocytochemical experiments, all data are presented as individual dots. Differences for individual groups were tested using the Mann-Whitney U-test (GraphPad Prism 4.03, GraphPad Software Inc., San Diego, CA, U.S.A.). pϽ0.05 was considered statistically significant.
RESULTS
Effect of the Distention with High Pressure on the Presence of Endothelial Cells in the Human SV
To assess the presence of functional endothelium in the distended SV, we examined the effect of acetylcholine (30 nM) on the distended SV precontracted with noradrenaline (1 mM). Acetylcholine did not induce vasodilation (data not shown). In the histochemical experiments, we also observed that the distended SV wall was mainly composed of smooth muscle cells, and almost all endothelial cells were desquamated (Fig. 3a) .
Effects of Sarpogrelate and SB224289 on the 5-HTInduced Vasoconstriction in the Distended Human SV The vasoconstriction induced by 5-HT (1.0 mM) was significantly inhibited by sarpogrelate at 0.03, 0.1 or 0.3 mM or by SB224289 at 0.03, 0.1 or 0.3 mM in a concentration-dependent manner. There were no significant differences between the inhibitory effects of sarpogrelate at 0.3 and 1.0 mM (Fig.  1a) or between the inhibitory effects of SB224289 at 0.3 and 1.0 mM (Fig. 1b) , and between the inhibitory effects of sarpogrelate and SB224289 on the 5-HT-induced vasoconstriction (Figs. 1a, b) . Sarpogrelate at 0.3 mM and SB224289 at 0.3 mM thus exerted the maximum inhibitory effects on 5-HTinduced vasoconstriction. Therefore, in the following experiment, we used sarpogrelate at 1.0 mM and SB224289 at 1.0 mM as supramaximum concentrations.
Cumulative Concentration-Response Curves for 5-HT Obtained with Distended Human SV in the Presence of Sarpogrelate, SB224289 or Sarpogrelate Plus SB224289 The cumulative addition of 5-HT caused vasoconstriction in a concentration-dependent manner. Treatment with either sarpogrelate (1.0 mM) or SB224289 (1.0 mM) significantly inhibited the 5-HT-induced vasoconstriction in similar manners (Fig. 2 ). There were no significant differences between the inhibitory effects of sarpogrelate and SB224289 (Fig. 2) . Simultaneous treatment with sarpogrelate (1.0 mM) and SB224289 (1.0 mM) almost completely inhibited the 5-HTinduced vasoconstriction (Fig. 2) . SV has been widely used as a vascular conduit in CABG surgery, but it has shorter patency than arterial ones. 21) This is due, in part, to the fact that distention of the SV with high intraluminal pressure induces functional and morphological alterations, which leads to early thrombosis and graft failure. 19, [21] [22] [23] Distention with high pressure is a routine part of surgical preparation of the SV for grafting in order to check for leaks and to increase the vascular diameter during perioperative and postoperative periods. During surgical preparation for grafting in individual hospitals, SV is distended with various degrees of pressure, which are sometimes very high. 19) Okon et al. 23) reported that the distention of the SV at pressures of up to 600 mmHg attenuated the contractile ability and impaired the endothelial function of the vessels. They also reported that the distention of the SV at the pressure range 100 to 300 mmHg augmented the contractile responses to depolarization and a-adrenergic stimulation in the vessels, and that, moreover, the endothelium-dependent dilation was either unchanged or even enhanced by the distension at this pressure range. In the present experiment, the SV segment was distended with pressure in the range of 200 to 400 mmHg achieved by injection of heparinized saline for 15 s. The distended SV segments did not retain functional endothelium because acetylcholine failed to induce vasodilation of the vessels preconstricted with noradrenaline. Furthermore, light and immunohistochemical microphotographs of the distended SV segment demonstrated that the venous wall was mainly composed of smooth muscle cells, and almost all endothelial cells were desquamated. In this study, we examined the vascular responsiveness in the distended human SV because the distended SV graft is implanted into the coronary artery circulation in CABG surgery.
Expression of 5-HT
We have previously reported that 5-HT-mediated platelet aggregation and vasoconstriction mainly contribute to occlusive thrombus formation in experimental animals. 24, 25) Clinical studies have revealed that 5-HT levels in the coronary artery sinus significantly increase in patients with acute coronary syndrome. 26, 27) Furthermore, 5-HT is released during coronary angioplasty and angiography, which causes clinically relevant vasoconstriction in patients with coronary artery disease. 12, 28) Thus, 5-HT is a crucial factor in coronary artery disease and subsequent cardiac events.
5-HT has been shown to be a potent vasoconstrictor of the various vasculatures. 8, 15) Although seven 5-HT receptor families have been identified so far, 5-HT 2A and/or 5-HT 1B/1D receptor subtypes are almost exclusively responsible for 5-HTinduced vasoconstriction in human vessels. [14] [15] [16] [17] [18] [29] [30] [31] [32] [33] [34] For example, in cerebral artery, 5-HT 1B receptors play a major role in 5-HT-induced vasoconstriction. 29) In ITA, 5-HT 2A and 5-HT 1B receptors equally contribute to the 5-HT-induced vasoconstriction. 18) Although it has been demonstrated that the coronary artery expresses both 5-HT 2A and 5-HT 1B receptors, relative contributions of receptor subtypes to 5-HT-induced vasoconstriction appear to vary among experimental conditions. 14, 15, [32] [33] [34] In the mesenteric artery, 5-HT caused potent vasoconstriction in all patient vessels used, but a selective 5-HT 1B receptor agonist GR127935 acted as a potent vasoconstrictor against only half of the patients and as a very weak vasoconstrictor against the remainder. 31) Borton et al. have reported that, in human SV, both 5-HT 2A and 5-HT 1B receptors mediate the 5-HT-induced vasoconstriction, 14) but the contribution of these receptor subtypes remains to be elucidated. The aim of the present study was to elucidate the relative contributions of 5-HT receptor subtypes responsible for 5-HT-induced vasoconstriction of the distended human SV.
It has been reported that sarpogrelate is a specific antagonist for the 5-HT 2A receptor. [35] [36] [37] [38] The selective inhibitory effect of sarpogrelate on 5-HT 2A receptors has been shown in the rat caudal artery, 35) rabbit platelets, 36) and the rat brain. 37, 38) SB224289 is a selective antagonist for the 5-HT 1B receptor. 39) In human arteries and veins from the thoracic wall, SB224289 has been shown to inhibit the vasoconstriction elicited by specific 5-HT 1B receptor agonists. 40) In the present study, we found that the supramaximum concentrations of sarpogrelate and SB224289 were 1.0 mM each in the distended SV segments. The inhibition of 5-HT-induced vasoconstriction by each antagonist at the supramaximum concentrations was incomplete; about half of the vasoconstriction still remained. The simultaneous treatment of sarpogrelate and SB224289 at the supramaximum concentrations almost completely inhibited the 5-HT-induced vasoconstriction. We also examined the distribution of the 5-HT 2A and 5-HT 1B receptors immunohistochemically in smooth muscle cells of the distended SV. Both 5-HT 2A and 5-HT 1B receptors were detected within the smooth muscle walls of the distended SV. Furthermore, there was no significant difference between the immunopositive areas of 5-HT 2A and 5-HT 1B receptors in smooth muscle cells of the distended SV. Taken together, these observations indicate that 5-HT 2A receptors and 5-HT 1B receptors similarly contribute to 5-HT-induced vasoconstriction in the human distended SV.
This study implies that, to prevent 5-HT-induced vasospasm, a combination of 5-HT 2A and 5-HT 1B receptor antagonists should be used, at least when the human distended SV is used as a CABG conduit.
